Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More

Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More

Singapore Clinical Trial: A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3537031 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3537031 in Healthy Participants

Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability ... Read More

Singapore Clinical Trial: A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer

Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab... Read More

Singapore Clinical Trial: A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Firmonertinib Compared with Investigator’s Choice of Osimertinib or Afatinib as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations (ALPACCA)

Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety o... Read More

Should social platforms require MyKad for age verification? Experts push for privacy-preserving methods

KUALA LUMPUR, July 29 -- As Malaysia approaches the implementation of the Online Safety Act 2025, an important debate is emerging over the legislation's age verification requirements. The discussion ... Read More

Anne Hathaway, Ewan McGregor add emotional weight to The End of Oak Street, says director David Robert Mitchell

India, July 29 -- Director David Robert Mitchell has praised Anne Hathaway and Ewan McGregor for bringing emotional depth and resilience to The End of Oak Street, saying their performances elevate the... Read More

Tom Holland becomes world's highest-grossing young actor with blockbuster box office run

India, July 29 -- Tom Holland has emerged as the world's highest-grossing young actor after a string of blockbuster successes, with his films collectively earning billions at the global box office and... Read More

Lakshmi arrives for Delhi women

India, July 29 -- After months of anticipation, the Delhi government on Tuesday unveiled the contours of its flagship Delhi Lakshmi Yojana, approving monthly financial assistance of Rs 2,500 for over ... Read More

Redington posts record revenue and PAT growth in Q2

New Delhi, July 29 -- Chennai-based Redington reported its highest ever quarterly net profit of Rs.486 crore for the first quarter ended June 2026, up 77 per cent from Rs.275 crore posted in the same ... Read More

• ««
• «
• 1151
• 1152
• 1153
• 1154
• 1155
• 1156
• 1157
• 1158
• 1159
• 1160
• »
• »»